Citigroup Maintains Neutral on Phibro Animal Health, Lowers Price Target to $44
Phibro Animal Health Corp PAHC
$34.18
▼ -0.55%
($-0.19)
Open
$34.50
Prev Close
$34.37
Day Range
$34.05 – $35.94
52W Range
$22.51 – $60.08
Market Cap
$1.39B
P/E (TTM)
14.68
Beta
0.56
Div Yield
1.40%
EPS (TTM)
$2.33
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2014-04-11 |
| Shares Out. | 40,530,000 |
| Website | pahc.com/ ↗ |
| Phone | 12013297300 |
Phibro Animal Health Corp is a publicly traded company under the ticker symbol PAHC on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
10 analysts (2026-05-01)
📰 Latest News for PAHC
Phibro Animal Health Corporation (PAHC) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Phibro Animal Health Corporation 2026 Q3 - Results - Earnings Call Presentation
Phibro Animal Health Corporation (PAHC) Q3 2026 Earnings Call Transcript
Transcript : Phibro Animal Health Corporation, Q3 2026 Earnings Call, May 07, 2026
Phibro Animal Health Corporation to Participate in Bank of America Securities Health Care Conference
Phibro Animal Health : Third Quarter - 2026 Presentation
Phibro Animal Health (NASDAQ:PAHC) Beats Q3 Estimates, But Stock Slides on Brazil Regulatory Uncertainty